Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Esophageal Neoplasms 1Endometrial Adenocarcinoma 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Bladder Urothelial Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Tamoxifen 12Chemotherapy, Adjuvant 9Radiotherapy 7Anastrozole 6Neoadjuvant Therapy 5Magnetic Resonance Spectroscopy 5Letrozole 5Gene Expression Profiling 5Psychiatric Rehabilitation 4Mass Spectrometry 4Immunohistochemistry 4Early Intervention, Educational 4Counseling 4Sentinel Lymph Node Biopsy 3Reverse Transcriptase Polymerase Chain Reaction 3High-Energy Shock Waves 3Fatty Acids, Omega-3 3Chromatography, High Pressure Liquid 3Biopsy 3afimoxifene 2Trastuzumab 2Surgical Procedures, Operative 2Soybean Proteins 2Simvastatin 2Radiotherapy, Conformal 2Radiation 2Methods 2Mastectomy 2Fish Oils 2Caregivers 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Intraductal, Noninfiltrating × Ogivri × Clear all
NCT00769379 2025-06-12

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

National Cancer Institute (NCI)

Phase 3 Completed
2,014 enrolled 16 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡